Current drug safety · 2024
COVID-19 Vaccination Program for Children: An Electronic Assessment of Symptoms.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Kumar Naman, Khora Arjun, Loomba Riya, Sharma Nikhil, Kumar Abhishek, Rana Ajay, Kamboj Rohit, Kamboj Sweta, Guarve Kumar, Guatam Surya Prakash
Аннотация
BACKGROUND: The evolution of COVID-19 vaccinations, which are mostly seen as crucial to curb the epidemic, is a result of remarkable and ground-breaking researches by scientists around the world.
OBJECTIVE: The main goal of this study was to identify the significant adverse reactions of these vaccines, specifically in Homo sapiens.
METHODS: In this research, a trial version of Qualtrics CoreXM software was used, and 18 questionnaires were prototyped as part of an online survey that was done in the northern part of India.
RESULTS: The dataset included survey responses from 286 vaccinated (Corbevax) respondents' samples detailing their demographics, daily activities, type of gastronomic preferences, and any prior illnesses. The data were collected between March 24, 2022, and April 26, 2022. After analysis, 70.98% of respondents who took the first dose of the medication experienced side effects, while 50.62% of respondents who took the second dose of the medication stated the same. The major side effects reported were injection site pain, fever, tiredness, body ache, headache, etc.
CONCLUSION: After conducting a poll on children (aged 12-18) who had received the COVID-19 vaccination, we concluded that immunizations rarely cause moderate side effects that are manageable.
OBJECTIVE: The main goal of this study was to identify the significant adverse reactions of these vaccines, specifically in Homo sapiens.
METHODS: In this research, a trial version of Qualtrics CoreXM software was used, and 18 questionnaires were prototyped as part of an online survey that was done in the northern part of India.
RESULTS: The dataset included survey responses from 286 vaccinated (Corbevax) respondents' samples detailing their demographics, daily activities, type of gastronomic preferences, and any prior illnesses. The data were collected between March 24, 2022, and April 26, 2022. After analysis, 70.98% of respondents who took the first dose of the medication experienced side effects, while 50.62% of respondents who took the second dose of the medication stated the same. The major side effects reported were injection site pain, fever, tiredness, body ache, headache, etc.
CONCLUSION: After conducting a poll on children (aged 12-18) who had received the COVID-19 vaccination, we concluded that immunizations rarely cause moderate side effects that are manageable.